Properties
Description
SGL5213 is a sodium-glucose cotransporter inhibitor, preventing the kidneys from reabsorbing glucose.
Molecular Formula
C37H55N3O8
Identity
Confirmed by NMR/HPLC/MS.
Applications
SGL5213 is an SGLT inhibitor used in metabolic research focusing on glucose transport and diabetes management.